About The Sprout Group
The Sprout Group is one of the oldest and largest venture capital firms in the US. Sprout Capital IX L.P. and its affiliated entities comprise a capital pool of $1.6 billion. With offices in Menlo Park and New York, Sprout focuses on helping to grow companies in the healthcare technology and information technology sectors. Since 1969, Sprout has helped finance more than 300 companies with combined sales exceeding $40 billion. Active investments in healthcare technology include Adeza Biomedical, Adolor, Affymax, Allos Therapeutics, Deltagen, ePocrates, Focus Technologies, Gryphon Sciences, IntraBiotics Pharmaceuticals, Kalypsys, Metabasis, NxStage Medical, Pharsight, PhaseForward, Phylos, Picoliter, Prometheus, Spotfire, Tripath, Variagenics, VascA, Visiogen, VNUS Medical and Xycyte. The Sprout Group is a venture capital affiliate of Credit Suisse First Boston. |
